Ekaterina Urch, MD
Sports Medicine · Bend, ORNPI 1548550890
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (31.5%), speaking fees and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 37.6% of the total. 2025 is the largest year on record at $13,269, more than ten times the $159 reported in 2019.
Across 172 payments — averaging $239.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$15K
- Steelhead Surgical Inc$15K
- Shoulder Innovations, Inc.$4K
- Stryker$4K
- Vericel Corporation$2K
- Johnson & Johnson$344
- plus $696 from 11 others
What the payments were for
- Speaking & faculty fees$11,25027%
- Travel & lodging$12,96331%
- Food & beverage$6,56516%
- Education$10,34225%
- Gifts$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 69 | $15,499 |
| Steelhead Surgical Inc | 42 | $15,083 |
| Shoulder Innovations, Inc. | 13 | $3,949 |
| Stryker | 22 | $3,592 |
| Vericel Corporation | 2 | $2,019 |
| Johnson & Johnson | 6 | $344 |
| Left Coast Surgical Inc | 1 | $173 |
| Wildwood Medical LLC | 3 | $140 |
| Miach Orthopaedics, Inc. | 1 | $119 |
| Ferring Pharmaceuticals Inc. | 6 | $87 |
| Bodycad USA Corp | 1 | $57 |
| Abbott | 1 | $25 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Medtronic | 1 | $20 |
| Bioventus LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Kinamed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,183 in reported general payments places this provider in the 85th percentile of 76 sports medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 64 | $1,247 |
| Diclofenac Sodium | 91 | $446 |
| Celecoxib | 11 | $443 |
| Tramadol Hcl | 16 | $53 |
| Meloxicam | 13 | $49 |
| Amoxicillin | 26 | $32 |
| Oxycodone Hcl | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Bend
- Scott JacobsonBend$117K
- Adam LindsayBend$71K
- Brett GingoldBend$8K
- Timothy BollomBend$8K
- Blake NonweilerBend$3K
- Robert AndrewsBend$1K
- Brent WendelBend$158
- Bryce BederkaPortland$105K
- Jeffrey TumanEugene$94K
- Dennis CrawfordPortland$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.